Transaction overview
The Estée Lauder Companies (US) has taken a minority stake in 111Skin, a London-based luxury skincare brand founded in 2012 by Dr. Yannis and Eva Alexandrides. The deal was announced on November 1, 2023, with the close date also set for that day. While financial details are undisclosed, industry sources estimate that 111Skin's annual net sales range between $40 million and $50 million. The acquisition underscores Estée Lauder’s strategy to enhance its skin care portfolio by partnering with innovative brands that have a strong digital presence.
Deal structure and financing
The exact equity and debt split for this investment is undisclosed, as are the terms regarding seller retained stakes or lock-up agreements. Given the private nature of the transaction, it is unclear whether existing investors such as SKKY Partners will retain their positions. Estée Lauder typically uses a mix of cash and equity to finance its acquisitions but no specific details were provided for this minority stake investment.
Strategic context
The strategic rationale behind Estée Lauder's acquisition of 111Skin lies in the brand’s unique position within the luxury skincare market, particularly its blend of medical-grade treatments and consumer-friendly formulations. The deal reflects Estée Lauder’s broader Beauty Reimagined strategy, which aims to align more closely with evolving consumer preferences for high-performance products that deliver visible results. With 40% of 111Skin's sales coming from North America, the partnership also provides an opportunity to expand into new geographic markets while leveraging existing strengths in China and Europe.
Regulatory path
As a minority stake investment without full ownership, this transaction likely did not require extensive regulatory scrutiny in terms of competition law. The jurisdictions potentially involved would include the United States due to Estée Lauder’s headquarters and significant operations there, as well as the UK given 111Skin's base. However, no specific filings were made public regarding antitrust reviews or merger clearance processes.
The investment represents a continuation of Estée Lauder’s approach towards brand expansion through strategic partnerships rather than full acquisitions, emphasizing growth potential in emerging markets and digital commerce channels.